Monday, September 25, 2023
10:00 AM ET | 2:00 PM UTC
See all time zones
Duration approximately 3 hours

Join us virtually September 25th for the 2023 IGCS-IGCAN Gynecologic Cancer Survivor-Caregiver Advocacy Summit. Our annual patient-focused event gathers the community to learn about and discuss topics of importance to gynecologic cancer survivor-patients, their caregivers and family members, and all those dedicated to patient advocacy and activism.

During the educational portion of the session, experts will share the latest updates and findings from clinical trials studying gynecologic oncology and explain how these research studies are helping to improve cancer diagnoses, treatment, care, and outcomes. We’ll also introduce a new communications initiative in which IGCAN members will be encouraged to share and reflect on their personal stories, utilizing their lived experiences to create a powerful public narrative and call to action.

During and in between panel sessions, participants will be given the opportunity to connect with others, ask questions, and share their experiences. Our goal is to create a supportive environment that will inspire and advance patient advocacy efforts worldwide. 

Registration is FREE but required. When registering, you must first sign in with your IGCS username and password or create a new guest account prior to registering. If you are receiving email communication directly from IGCS, you already have an account. If you have forgotten your password, please click here. For further assistance with your IGCS account, contact igcs@igcs.org.  

The Summit will begin with two expert clinician-researchers sharing and analyzing the latest updates in gynecologic oncology. Dr. Robert Coleman will explain what you need to know about recent findings from select clinical trials and Dr. Gottfried Konency will help us understand biomarkers and how the molecular underpinnings of gynecologic cancers translate into novel treatment approaches. These educational presentations will explain how research is helping to improve cancer diagnoses, treatment, care, and outcomes.  

Robert Coleman, MD Vaniam Group  USA

Gottfried Konency, MD UCLA USA